Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Alzheimer's disease | R-HSA-1643685 | 0 | CP-645525-01 | None | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | CP-645525-01 | None | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | CP-645525-01 | None | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | CP-645525-01 | None | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | CP-645525-01 | None | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | CP-645525-01 | None | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | CP-645525-01 | None | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | CP-645525-01 | None | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | abamectin | 156391 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | abamectin | 156391 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | abamectin | 156391 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | abamectin | 156391 | drug-path |
Asthma | R-HSA-444620 | map05310 | abamectin | 156391 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | abamectin | 156391 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | abamectin | 156391 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | abamectin | 156391 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | abamectin | 156391 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | abamectin | 156391 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | abamectin | 156391 | drug-path |
Non-small cell lung cancer | R-HSA-5619066 | map05223 | abamectin | 156391 | drug-path |